SCHEMBL26129596

SCHEMBL26129596

NC1(C(=O)O)CCc2ccc(Oc3ccccc3-c3cccc(Cl)c3)cc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.36
P2RX4 Q99571 2/20 0.36
GABRA1 P14867 1/20 0.36
ADRA2C P18825 1/20 0.36
LMNA P02545 1/20 0.36
HSD17B3 P37058 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
STK39 Q9UEW8 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
PLA2G1B P04054 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
RORC P51449 1/20 0.34
RORB Q92753 1/20 0.34
SCN9A Q15858 1/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
PTGIR P43119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31232598 1.00 TMEM97 (0.36) TMEM97P2RX4GABRA1ADRA2CLMNA
Hydrochloric Acid SCHEMBL26129547 0.99 TMEM97 (0.36) TMEM97P2RX4GABRA1ADRA2CLMNA
SCHEMBL26404755 0.91 NCOA1 (0.43) NCOA1NCOA3SCN9APRMT5WDR77
SCHEMBL26405920 0.90 SCN9A (0.39) HSD17B3STK39NCOA1NCOA3SCN9A
Hydrochloric Acid SCHEMBL26130499 0.90 NCOA1 (0.42) NCOA1NCOA3SCN9APRMT5WDR77
Hydrochloric Acid SCHEMBL26126752 0.89 SCN9A (0.38) HSD17B3PTGDR2STK39NCOA1NCOA3
SCHEMBL31232693 0.88 SCN9A (0.38) ADRA2CNCOA1NCOA3SCN9APRMT5
SCHEMBL31232479 0.88 FEN1 (0.38) NCOA1NCOA3SCN9APRMT5WDR77
SCHEMBL26130836 0.88 FEN1 (0.38) NCOA1NCOA3SCN9APRMT5WDR77
SCHEMBL26129734 0.88 SCN9A (0.38) ADRA2CNCOA1NCOA3SCN9APRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035339-A1 TETRAHYDRONAPHTHALENE DERIVATIVE ATRANSEN PHARMA LTD (JP) 2026-02-05 US disclosed
EP-4501906-A1 TETRAHYDRONAPHTHALENE DERIVATIVE Atransen Pharma Ltd. (JP) 2025-02-05 EP disclosed
WO-2023190878-A1 TETRAHYDRONAPHTHALENE DERIVATIVE Atransen Pharma株式会社 2023-10-05 WO disclosed
WO-2023190878-A1 TETRAHYDRONAPHTHALENE DERIVATIVE Atransen Pharma株式会社 2023-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035339-A1 TETRAHYDRONAPHTHALENE DERIVATIVE LATS1, LATS2, BCAT1 TMEM97 2101/4885P2RX4 4754/4885GABRA1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.